Election-night cannabis victories in Massachusetts and Idaho have different practical effects: one protects an existing market, while the other preserves a route to future reform.
Organigram and Aurora have agreed to a Canadian cannabis combination. The proposed deal’s value, competing bid and approval process explain what changes now—and what still has...
A Maryland proposal would let dispensaries show and offer the aroma of cannabis under security conditions. Its timing and accompanying retail changes deserve a closer look.
A Shibuya screening puts cannabis comedy in conversation with hemp culture, film and public discussion, with a separate online audience award extending into 2027.
A Senate amendment would let qualifying veterans use VA diagnosis records for medical cannabis registration. It remains a proposal ahead of November 5 consideration.
A preliminary AHA survey analysis links recent cannabis use with cardiovascular history. What the findings can—and cannot—tell consumers.
Idaho votes November 3 on who can legalize cannabis. Here is what HJR 4 would change—and why neither outcome immediately legalizes marijuana.
Sunday’s results delivered a debut victory, a returning champion and a close American podium finish. CBD’s place in sport remains a separate question.
The Mount Dora gathering pairs live music with cannabis-focused exhibitors, while admission and Florida’s medical program remain separate matters.
A newly published survey points to an education and communication problem around cannabinoids, while its methods place clear limits on broad claims about athletes.